Hasil Pencarian - Anouk Emadali

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer

    BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer oleh Azadeh Hajmirza, Anouk Emadali, Arnaud Gauthier, Olivier Casasnovas, Rémy Gressin, Mary B. Callanan

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP–treated DLBCL

    Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP–treated DLBCL oleh Antonin Bouroumeau, Lucile Bussot, Hervé Sartelet, Cyril Fournier, Patricia Betton-Fraisse, Edwige Col, Laurence David-Boudet, Anne McLeer, Christine Lefebvre, Tatiana Raskovalova, Marie-Christine Jacob, Claire Vettier, Simon Chevalier, Caroline Algrin, Sylvain Carras, Rémy Gressin, Mary B. Callanan, Thierry Bonnefoix, Anouk Emadali

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma

    c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma oleh Antonin Bouroumeau, Lucile Bussot, Thierry Bonnefoix, Cyril Fournier, Caroline Chapusot, Olivier Casasnovas, Laurent Martin, Anne McLeer, Edwige Col, Laurence David‐Boudet, Christine Lefebvre, Caroline Algrin, Tatiana Raskovalova, Marie‐Christine Jacob, Claire Vettier, Simon Chevalier, Mary B Callanan, Rémy Gressin, Anouk Emadali, Hervé Sartelet

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of <i>TP53</i> mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group

    Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of <i>TP53</i> mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA g... oleh Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Selim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joel Fleury, Fabrice Jardin, Clementine Sarkozy, Ghandi Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cecile Chabrot, Veronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Reda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morineau, Marie Pierre Moles, Hacene Zerazhi, Jean Fontan, Yazid Arkam, Magda Alexis, Vincent Delwail, Jean Pierre Vilque, Loic Ysebaert, Barbara Burroni, Mary Callanan, Steven Le Gouill, Rémy Gressin

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: